Document Detail


Hybrid myocardial revascularization: an integrated approach to coronary revascularization.
MedLine Citation:
PMID:  20333704     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Coronary artery bypass surgery is beneficial in patients with complex coronary artery disease. The longevity of the left internal mammary artery (LIMA) placed to the left anterior descending (LAD) artery (LIMA-LAD) is between 92-99% at 15 years, and contributes substantially to the survival advantage in patients treated with surgical revascularization. The long-term patency of saphenous vein grafts (SVGs), commonly used (>95%) in surgical revascularization procedures, is less well-established, with up to 26% of SVGs failing in the first year. In selected patients, particularly in those patients with vessels poorly suited to SVGs, hybrid myocardial revascularization (HMR) has been used, combining a minimally invasive approach to the LIMA-LAD with drug-eluting stent placement of the non-LAD vessels. The advantages and disadvantages of hybrid myocardial revascularization are reviewed in this report.
Authors:
Jeffrey J Popma; Senthil Nathan; Robert C Hagberg; Kamal R Khabbaz
Related Documents :
8893574 - Hypertension increases the contractions to sumatriptan in the human internal mammary ar...
11157714 - Use of the internal mammary artery graft and in-hospital mortality and other adverse ou...
2319794 - Comparative anatomic studies of various arterial conduits for myocardial revascularizat...
3558184 - Anatomy of diaphragmatic circulation.
18496204 - Is an angiographically obliterated aneurysm always secure?
18295704 - Efficacy of a polyphosphazene nanocoat in reducing thrombogenicity, in-stent stenosis, ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  75 Suppl 1     ISSN:  1522-726X     ISO Abbreviation:  Catheter Cardiovasc Interv     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-29     Completed Date:  2010-06-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S28-34     Citation Subset:  IM    
Copyright Information:
(c) 2010 Wiley-Liss, Inc.
Affiliation:
Cardiovascular Division, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA. jpopma@bidmc.harvard.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary* / adverse effects,  instrumentation
Combined Modality Therapy
Coronary Artery Bypass* / adverse effects
Coronary Artery Disease / physiopathology,  surgery,  therapy*
Drug-Eluting Stents
Graft Occlusion, Vascular / etiology,  prevention & control
Humans
Patient Selection
Risk Assessment
Time Factors
Treatment Outcome
Vascular Patency

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Contemporary principles of coronary chronic total occlusion recanalization.
Next Document:  Contrast media and clotting: What is the evidence?